Tinnitus. Noise Effects On Inner Ear
Conditions
Interventions
Intervention 1: Group A: receiving Cinnarizine, after randomization we gave to patients Cinnarizine tablets of 25 mg (manufactured by Osve Company). If patients who had failed to respond effectively,
Treatment - Drugs
Placebo
Group A: receiving Cinnarizine, after randomization we gave to patients Cinnarizine tablets of 25 mg (manufactured by Osve Company). If patients who had failed to respond effectively, (THI>30) interve
Group B: receiving herbal formulation (Salvia hydrange, Citrus aurantium, Lipiacitriodora, and Elmbark), ), formulation in sealed packages (4 g of each herb and 12 g of elmbark) with a cup and recipe
placebo in the form of gelatin capsules containing starch was prescribed for 28 days.
Sponsors
Birjand University of Medical Sceinces
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: giving consent to participate in the study, having an age of 17-70 years old, and suffering from tinnitus for more than 4 months. Exclusion criteria: otitis media, ear tumor, deformity within the ear; ototoxic drugs like gentamicin; ear surgery, pregnancy, breastfeeding or taking birth control pills, extensive surgery or blood transfusion during the previous month, kidney failure, history of stroke or thyroid disease, Otosclerosis, addiction to drugs or alcohol; occupational exposure to noise
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus Severity. Timepoint: Following at first, one month and if it was needed 2 month later. Method of measurement: Phisical Examination, Audiometry. | — |
Secondary
| Measure | Time frame |
|---|---|
| Failure Criterion of Tinnitus. Timepoint: ?At First and One Month Later. Method of measurement: THI & VAS Scales. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMansour Soltani
Paramedic Faculty
Outcome results
None listed